22nd Century Group Inc.
7.95
1.60 (25.20%)
At close: Jan 15, 2025, 9:52 AM

Company Description

22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries.

It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies.

The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.

22nd Century Group Inc.
22nd Century Group Inc. logo
Country United States
IPO Date Jan 26, 2011
Industry Tobacco
Sector Consumer Defensive
Employees 64
CEO Lawrence D. Firestone

Contact Details

Address:
500 Seneca Street
Buffalo, New York
United States
Website https://www.xxiicentury.com

Stock Details

Ticker Symbol XXII
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001347858
CUSIP Number 90137F103
ISIN Number US90137F2020
Employer ID 98-0468420
SIC Code 2111

Key Executives

Name Position
Lawrence D. Firestone President, Chief Executive Officer & Chairman
Daniel A. Otto Chief Financial Officer & Principal Accounting Officer
James C. Morrison Technical Advisor & Regulatory Affairs Consultant
Jonathan Staffeldt General Counsel & Secretary
Matthew Kreps Investor Relations
Robert P. Manfredonia Executive Vice President of Sales and Marketing
Scott Marion Vice President of Operations

Latest SEC Filings

Date Type Title
Jan 13, 2025 8-K Current Report
Jan 07, 2025 8-K Current Report
Dec 17, 2024 8-K Current Report
Dec 06, 2024 8-K Current Report
Dec 03, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 12, 2024 10-Q Quarterly Report
Nov 12, 2024 8-K Current Report
Nov 08, 2024 424B3 Filing
Nov 01, 2024 S-3 Filing